Related Experiment Video
Updated: Jul 12, 2026

10:16
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Stem cell therapy: a hope for dying hearts.
1Division of Pharmacology, Central Drug Research Institute, POB-173, Lucknow-226001, India.
Stem Cells and Development
|September 6, 2007
Summary
Stem cell therapy offers a promising approach to repair heart damage after myocardial infarction by regenerating cardiac tissue. However, challenges remain in sourcing functional cells and ensuring successful engraftment for improved heart function.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Background:
- Heart failure and myocardial infarction cause irreversible damage and left ventricular remodeling.
- Current treatments fail to regenerate dead myocardium or replace necrotic cardiac myocytes.
- The heart's potential for regeneration via resident or recruited stem cells challenges previous notions.
Purpose of the Study:
- To review the potential of stem cell therapy for myocardial repair.
- To discuss challenges in stem cell sourcing and functional cardiomyocyte generation.
- To analyze discrepancies in clinical trial outcomes and detection methods for stem cell integration.
Main Methods:
- Comprehensive literature review of stem cell therapy for heart failure.
- Analysis of stem cell characteristics, isolation, expansion, and engraftment.
- Evaluation of clinical trial data and detection methodologies for stem cell integration.
Main Results:
- Stem cell therapy shows promise for myocardial repair, challenging the concept of poor cardiac regeneration.
- Paucity of functional cardiomyocyte sources and variable cell characteristics hinder progress.
- Clinical trials suggest potential benefits of extracardiac stem cells, but results are complicated by detection and identification issues.
Conclusions:
- Stem cell therapy is a promising avenue for treating heart failure post-myocardial infarction.
- Addressing challenges in cell sourcing and engraftment is crucial for therapeutic success.
- Further research is needed to clarify stem cell integration and functional outcomes in human hearts.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

